August 27, 2025

AstraZeneca’s INTERSTELLAR Study: Real-World Insights into Anifrolumab for Lupus – TipRanks

August 27, 2025

AstraZeneca’s Promising Phase 3 Study on Anifrolumab for Lupus Nephritis: Key Insights for Investors – TipRanks

August 25, 2025

Novel Anti-CD40 Antibody Shows Promise in Lupus Nephritis – Medscape

August 24, 2025

AbbVie’s Upadacitinib Study: A Potential Breakthrough for Lupus Treatment – TipRanks

August 11, 2025

Sjögren’s Disease and Systemic Lupus Erythematosus Overlap: Immunological Insights and Therapeutic Implications Authors – Frontiers